berberine has been researched along with Cancer of Stomach in 17 studies
Excerpt | Relevance | Reference |
---|---|---|
"Gastric cancer is a prevalent malignant tumor that seriously affects human health." | 1.72 | Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6. ( Fan, J; Huang, L; Li, X; Ren, L; Xu, M; Ye, X; Zhou, L, 2022) |
"Treatment with berberine triggered cell autophagy, as demonstrated by the punctuate distribution of monodansylcadaverine staining and GFP-LC3, as well as the LC3-II, Beclin-1 and p-ULK1 promotion, and p62 degradation." | 1.56 | Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. ( Cao, S; Duan, J; He, X; Jiang, B; Kang, N; Qiu, F; Sun, Y; Wang, X; Yu, Y; Zhang, Q, 2020) |
"Berberine (BBR) is a traditional Chinese medicine normally used for gastroenteritis, and recent research found that it could fight against tumors." | 1.48 | Integration of microRNA-mRNA profiles and pathway analysis of plant isoquinoline alkaloid berberine in SGC-7901 gastric cancers cells. ( Chen, J; Li, K; Qiu, L; Yang, Y; Zhang, J; Zhang, N, 2018) |
"Gastric cancer is the second leading cause of cancer-associated mortality worldwide." | 1.43 | MAPK pathways are involved in the inhibitory effect of berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in vivo. ( Li, HL; Shi, HL; Wu, H; Wu, XJ; Zhang, BB, 2016) |
"Berberine was found to inhibit growth in GC cell lines and to induce apoptosis." | 1.43 | Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer. ( Cai, X; Cao, H; Chen, Z; Dong, J; Fan, D; Hao, J; Jin, T; Lu, D; Nie, Y; Wang, J; Wang, R; Yang, S; Zhang, S, 2016) |
"Berberine was more effective in inhibiting survivin expression as compared to other herbal agents." | 1.42 | Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil. ( Bharti, AC; Dwivedi, M; Mahata, S; Mehrotra, R; Misra, SP; Misra, V; Pandey, A; Tripathi, SC; Vishnoi, K, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 5 (29.41) | 2.80 |
Authors | Studies |
---|---|
Xu, M | 1 |
Ren, L | 1 |
Fan, J | 1 |
Huang, L | 1 |
Zhou, L | 1 |
Li, X | 1 |
Ye, X | 1 |
Peng, Z | 1 |
Wangmu, T | 1 |
Li, L | 1 |
Han, G | 1 |
Huang, D | 1 |
Yi, P | 1 |
Liu, Q | 1 |
Tang, J | 2 |
Chen, S | 1 |
Hu, S | 1 |
Shen, C | 2 |
Xiang, J | 1 |
Chen, N | 2 |
Wang, J | 2 |
Ma, X | 1 |
Zhang, Y | 1 |
Zeng, J | 2 |
Zhao, M | 1 |
Yang, Y | 2 |
Nian, Q | 1 |
Xiao, X | 1 |
Liao, W | 1 |
Zheng, Q | 1 |
Zhang, G | 1 |
Gong, D | 1 |
Wen, Y | 1 |
Zhang, Q | 1 |
Wang, X | 1 |
Cao, S | 1 |
Sun, Y | 1 |
He, X | 1 |
Jiang, B | 1 |
Yu, Y | 1 |
Duan, J | 1 |
Qiu, F | 1 |
Kang, N | 1 |
Zhang, N | 1 |
Li, K | 1 |
Chen, J | 1 |
Qiu, L | 1 |
Zhang, J | 1 |
Shi, HL | 2 |
Wu, XJ | 2 |
Liu, Y | 1 |
Xie, JQ | 1 |
Zhang, XZ | 1 |
Wang, L | 1 |
Liu, DW | 1 |
Tang, GY | 1 |
Zhang, HY | 1 |
Yi, T | 1 |
Zhuang, L | 1 |
Song, G | 1 |
Zhang, B | 1 |
Li, G | 1 |
Hu, T | 1 |
Pandey, A | 1 |
Vishnoi, K | 1 |
Mahata, S | 1 |
Tripathi, SC | 1 |
Misra, SP | 1 |
Misra, V | 1 |
Mehrotra, R | 1 |
Dwivedi, M | 1 |
Bharti, AC | 1 |
You, HY | 1 |
Xie, XM | 1 |
Zhang, WJ | 1 |
Zhu, HL | 1 |
Jiang, FZ | 1 |
Li, HL | 1 |
Wu, H | 1 |
Zhang, BB | 1 |
Yang, S | 1 |
Cai, X | 1 |
Dong, J | 1 |
Chen, Z | 1 |
Wang, R | 1 |
Zhang, S | 1 |
Cao, H | 1 |
Lu, D | 1 |
Jin, T | 1 |
Nie, Y | 1 |
Hao, J | 1 |
Fan, D | 1 |
Lin, JP | 1 |
Yang, JS | 1 |
Lee, JH | 1 |
Hsieh, WT | 1 |
Chung, JG | 1 |
Lin, HL | 1 |
Liu, TY | 1 |
Wu, CW | 1 |
Chi, CW | 1 |
Iwasa, K | 1 |
Moriyasu, M | 1 |
Yamori, T | 1 |
Turuo, T | 1 |
Lee, DU | 1 |
Wiegrebe, W | 1 |
Wang, MX | 1 |
Huo, LM | 1 |
Yang, HC | 1 |
Gao, YJ | 1 |
E, Z | 1 |
2 reviews available for berberine and Cancer of Stomach
Article | Year |
---|---|
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
Topics: Anti-Bacterial Agents; Berberine; Carcinogenesis; Cytokines; Gastritis; Gastritis, Atrophic; Helicob | 2022 |
Phytochemicals and mitochondria: Therapeutic allies against gastric cancer.
Topics: Apoptosis; Berberine; Cell Line, Tumor; Humans; Mitochondria; Phytochemicals; Reactive Oxygen Specie | 2023 |
15 other studies available for berberine and Cancer of Stomach
Article | Year |
---|---|
Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Topics: Animals; Apoptosis; Berberine; Cell Line, Tumor; Cell Movement; Cell Proliferation; China; Gene Expr | 2022 |
Combination of berberine and low glucose inhibits gastric cancer through the PP2A/GSK3β/MCL-1 signaling pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Glucose; Glycogen Synthase Kinase 3 beta; Huma | 2022 |
Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
Topics: Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Berberine; Cell Line, Tumor; | 2020 |
Integration of microRNA-mRNA profiles and pathway analysis of plant isoquinoline alkaloid berberine in SGC-7901 gastric cancers cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Cell Line, Tumor; Cell Proliferation; Down- | 2018 |
Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Cell Adhesion; Cell Cycle; Cell Movement; Cell Prolife | 2013 |
Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Caspase 3; Cell Cycle Checkpoints; Cell Lin | 2014 |
Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells.
Topics: Animals; Apoptosis; Berberine; Cell Line, Tumor; Female; Humans; Mice; Mice, Inbred BALB C; Mitochon | 2015 |
Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil.
Topics: Berberine; Cell Line, Tumor; Cell Survival; Curcumin; DNA; Drug Resistance, Neoplasm; Drug Synergism | 2015 |
Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Berberine; Cell Line, Tumor; Cell Proliferation; Cisplatin | 2016 |
MAPK pathways are involved in the inhibitory effect of berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Berberine; Cell Line, Tumor; Cell Proliferation; Disease Models, Ani | 2016 |
Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell | 2016 |
Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Berberine; Calcium; Caspase 3; Caspase Inhibitors; Cell | 2006 |
Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Carcinoma; C | 1999 |
In vitro cytotoxicity of the protoberberine-type alkaloids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Berberine Alkaloids; Brain Neoplasms; Breast | 2001 |
An experimental study on the photodynamic activity of berberine in vitro on cancer cells.
Topics: Berberine; Berberine Alkaloids; Cell Line; Humans; Microscopy, Fluorescence; Photochemotherapy; Stom | 1986 |